Aptamers as therapeutic and diagnostic reagents: problems and prospects.

Aptamers are nucleic acid molecules that bind specific ligands. Barriers to the application of aptamers as therapeutic and diagnostic reagents have been overcome in the past several years. In particular, aptamers that bind biomedically relevant targets have proven to be efficacious at modifying cellular metabolism. Such aptamers can be stabilized by chemical modifications and potentially used in vivo. Researchers have begun to devise aptamer-based diagnostic assays that may rival more conventional immunoassays.

[1]  In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. , 1995, Chemistry & biology.

[2]  Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Vargeese,et al.  Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. , 1995, Biochemistry.

[4]  N. Janjić,et al.  Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. , 1995, Chemistry & biology.

[5]  Michael R. Green,et al.  HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA , 1991, Cell.

[6]  L E Orgel,et al.  Selection in vitro , 1979, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[7]  Y. Lin,et al.  Modified RNA sequence pools for in vitro selection. , 1994, Nucleic acids research.

[8]  A D Ellington,et al.  RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo , 1996, Journal of virology.

[9]  S D Jayasena,et al.  Use of a high affinity DNA ligand in flow cytometry. , 1996, Nucleic acids research.

[10]  J. Latham,et al.  The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. , 1994, Nucleic acids research.

[11]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[12]  L. Gold,et al.  High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. , 1995, Biochemistry.

[13]  J. Wills,et al.  Isolation of virus-neutralizing RNAs from a large pool of random sequences. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Gold,et al.  Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus. , 1996, Biochemistry.

[15]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[16]  M Yarus,et al.  Diversity of oligonucleotide functions. , 1995, Annual review of biochemistry.

[17]  A D Ellington,et al.  Detecting immobilized protein kinase C isozymes with RNA aptamers. , 1996, Analytical biochemistry.

[18]  N. Janjić,et al.  Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. , 1994, Biochemistry.

[19]  Design, synthesis, and analysis of disulfide cross-linked DNA duplexes , 1996 .

[20]  L. C. Bock,et al.  In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. , 1993, Blood.

[21]  N. Janjić,et al.  High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A D Ellington,et al.  Isozyme-specific inhibition of protein kinase C by RNA aptamers. , 1994, The Journal of biological chemistry.

[23]  J. Kinet,et al.  High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. , 1996, Journal of immunology.

[24]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[25]  L. Gold,et al.  Let's get specific: the relationship between specificity and affinity. , 1995, Chemistry & biology.

[26]  Robert L. Letsinger,et al.  Use of a Stilbenedicarboxamide Bridge in Stabilizing, Monitoring, and Photochemically Altering Folded Conformations of Oligonucleotides , 1995 .

[27]  T. Fitzwater,et al.  Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor , 1997, Nature Biotechnology.

[28]  D. Drolet,et al.  An enzyme-linked oligonucleotide assay , 1996, Nature Biotechnology.

[29]  Andrew D. Ellington,et al.  Nucleic Acid Selection and the Challenge of Combinatorial Chemistry. , 1997, Chemical reviews.

[30]  A. Ellington,et al.  Incorporation of a non-nucleotide bridge into hairpin oligonucleotides capable of high-affinity binding to the Rev protein of HIV-1. , 1996, Biochemistry.

[31]  L. Gold,et al.  Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Engelke,et al.  Expression of small, therapeutic RNAs in human cell nuclei , 1997, Gene Therapy.

[33]  A. Ellington,et al.  In vitro selection of aptamers: the dearth of pure reason. , 1996, Current opinion in structural biology.

[34]  A. Bertelsen,et al.  Structural and functional characterization of potent antithrombotic oligonucleotides possessing both quadruplex and duplex motifs. , 1995, Biochemistry.